MedicarePartD.guide

A non-government resource built from CMS public data

Overactive bladder drugs on every 2026 Virginia Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 9 stand-alone Part D plans in Virginia cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Overactive bladder drugs by 2026 Virginia Part D plan
DrugWellcare Classic$0.00/moS4802-069Wellcare Value Script$0.00/moS4802-142Humana Basic Rx Plan$0.00/moS5884-132Humana Value Rx Plan$0.00/moS5884-186AARP Medicare Rx Saver from UHC$39.60/moS5921-352SilverScript Choice$78.20/moS5601-014Humana Premier Rx Plan$87.60/moS5884-153AARP Medicare Rx Preferred from UHC$100.80/moS5921-389HealthSpring Assurance Rx$133.80/moS5617-216
oxybutyningeneric DitropanTier 325%QL 60/30dTier 440%QL 60/30dTier 2$1.00Tier 2$0.00Tier 3PA17%Tier 2$7.00QL 120/30dTier 2$4.00Tier 2PA$10.00Tier 2$2.00
solifenacingeneric VesicareTier 431%QL 30/30dTier 440%QL 30/30dTier 433%QL 30/30dTier 2$0.00QL 30/30dTier 4PA34%QL 30/30dTier 2$7.00QL 30/30dTier 2$4.00QL 30/30dTier 3PA17%QL 30/30dTier 431%
MyrbetriqmirabegronNot coveredNot coveredTier 325%QL 30/30dTier 320%QL 30/30dNot coveredTier 318%QL 30/30dTier 3$45.00QL 30/30dTier 317%Tier 322%
mirabegrongeneric MyrbetriqTier 325%QL 30/30dTier 325%QL 30/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
GemtesavibegronNot coveredTier 440%QL 30/30dNot coveredNot coveredTier 317%Tier 318%QL 30/30dNot coveredTier 435%Not covered
tolterodinegeneric DetrolTier 431%QL 60/30dTier 440%QL 60/30dTier 433%QL 60/30dTier 432%QL 60/30dNot coveredTier 433%QL 60/30dTier 450%QL 60/30dTier 435%Tier 431%
trospiumgeneric SancturaTier 325%QL 60/30dTier 325%QL 60/30dTier 433%Tier 432%Not coveredTier 2$7.00QL 60/30dTier 450%Tier 317%Not covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.